Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

GE and Karolinska partner to improve care pathway for pelvic cancer patients

GE Healthcare, a provider of transformational medical technologies and services, and Karolinska University Hospital have announced a partnership to improve the efficiency of the care pathway for pelvic cancer patients and reduce unwarranted clinical variation.

Published By MarketLine
21 Oct 2014
NewsWire
NewsWire

Bausch + Lomb appoints directors of professional strategy

Bausch + Lomb, an eye health company, has announced the newly created positions and appointments of Jill Saxon and Todd Love as directors of professional strategy.

Published By MarketLine
21 Oct 2014
NewsWire
NewsWire

Cubist Pharmaceuticals names CEO

Cubist Pharmaceuticals, Inc., a biopharmaceutical company, has named Robert Perez as the company's CEO, effective January 1, 2015.

Published By MarketLine
21 Oct 2014
NewsWire
NewsWire

Astellas and CoMentis to end commercialization agreement

Astellas Pharma Inc. and CoMentis, Inc., a biotech company, have announced that the companies will end their collaboration agreement for research, development and commercialization of beta-secretase inhibitors for Alzheimer's disease, signed in 2008.

Published By MarketLine
21 Oct 2014
NewsWire
NewsWire

Progenics announces encouraging data from Phase II prostate cancer trial

Progenics Pharmaceuticals, Inc., a biopharmaceutical company, has announced data from a Phase II trial of its PSMA imaging agent candidate, 1404, a targeted small molecule designed to visualize prostate cancer by targeting prostate specific membrane antigen, or PSMA.

Published By MarketLine
21 Oct 2014
NewsWire
NewsWire

PDS deploys Quality Systems's cloud-based software

Quality Systems, Inc., a provider of practice management and electronic health record applications, has announced that its dental division has entered an agreement with Pacific Dental Services, or PDS, to deploy QSIDental Web across its enterprise of 400 supported dental practices in the western, central and southeastern US.

Published By MarketLine
21 Oct 2014
NewsWire
NewsWire

Osiris enters into commercial and development partnership with Arthrex

Osiris Therapeutics, Inc., a cellular and regenerative medicine company, has entered into a commercial and development partnership for its cartilage product, Cartiform, with Arthrex, Inc., a medical device company.

Published By MarketLine
21 Oct 2014
NewsWire
NewsWire

Sanofi Pasteur and Immune collaborate for development of HSV immune therapy

Sanofi Pasteur, the vaccines division of Sanofi, and Immune Design Corp., a clinical-stage immunotherapy company, have entered into collaboration for the development of a herpes simplex virus, or HSV, immune therapy.

Published By MarketLine
21 Oct 2014
NewsWire
NewsWire

Boston Scientific initiates coronary artery disease trial

Boston Scientific Corporation, a developer of medical devices, has initiated the PLATINUM Diversity trial to evaluate the clinical performance of the Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System in underserved patient populations, including women and people of color.

Published By MarketLine
21 Oct 2014
NewsWire
NewsWire

Aspen Malaysia selects DKSH to provide services for Dequadin and Cortal

Aspen Malaysia, a pharmaceutical company, has selected DKSH Holding AG to provide marketing, sales and distribution services for its consumer health brands Dequadin and Cortal.

Published By MarketLine
21 Oct 2014

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.